CD4⁺CD25⁺ regulatory T-cell therapy

References

• Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol.6(4), 345–352 (2005).
   PubMed Web of Science ®Google Scholar
• Hawrylowicz CM, O'Garra A. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat. Rev. Immunol.5(4), 271–283 (2005).
   PubMed Web of Science ®Google Scholar
• Jiang S, Lechler RI. Regulatory T cells in the control of transplantation tolerance and autoimmunity. Am. J. Transplant.3(5), 516–524 (2003).
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol.155(3), 1151–1164 (1995).
   PubMed Web of Science ®Google Scholar
• Ng WF, Duggan PJ, Ponchel F et al. Human CD4+CD25+ cells: a naturally occurring population of regulatory T cells. Blood98(9), 2736–2744 (2001).
   PubMed Web of Science ®Google Scholar
• Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH. Identification and functional characterization of human CD4+CD25+ T cells with regulatory properties isolated from peripheral blood. J. Exp. Med.193(11), 1285–1294 (2001).
   PubMed Web of Science ®Google Scholar
• Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G. Ex vivo isolation and characterization of CD4+CD25+ T cells with regulatory properties from human blood. J. Exp. Med.193(11), 1303–1310 (2001).
   PubMed Web of Science ®Google Scholar
• Levings MK, Sangregorio R, Roncarolo MG. Human CD25+CD4+ T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med.193(11), 1295–1302 (2001).
   PubMed Web of Science ®Google Scholar
• Modigliani Y, Coutinho A, Pereira P et al. Establishment of tissue-specific tolerance is driven by regulatory T cells selected by thymic epithelium. Eur. J. Immunol.26(8), 1807–1815 (1996).
   PubMed Web of Science ®Google Scholar
• Jordan MS, Boesteanu A, Reed AJ et al. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol.2(4), 301–306 (2001).
   PubMed Web of Science ®Google Scholar
• Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science299(5609), 1057–1061 (2003).
   PubMed Web of Science ®Google Scholar
• Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol.4(4), 330–336 (2003).
   PubMed Web of Science ®Google Scholar
• Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol.4(4), 337–342 (2003).
   PubMed Web of Science ®Google Scholar
• Bennett CL, Christie J, Ramsdell F et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet.27(1), 20–21 (2001).
   PubMed Web of Science ®Google Scholar
• Watanabe N, Wang YH, Lee HK et al. Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature436(7054), 1181–1185 (2005).
   PubMed Web of Science ®Google Scholar
• Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol.6(11), 1142–1151 (2005).
   PubMed Web of Science ®Google Scholar
• D’Cruz LM, Klein L. Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling. Nat. Immunol.6(11), 1152–1159 (2005).
   PubMed Web of Science ®Google Scholar
• Setoguchi R, Hori S, Takahashi T, Sakaguchi S. Homeostatic maintenance of natural Foxp3+ CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med.201(5), 723–735 (2005).
   PubMed Web of Science ®Google Scholar
• Bayer AL, Yu A, Adeegbe D, Malek TR. Essential role for interleukin-2 for CD4+CD25+ T regulatory cell development during the neonatal period. J. Exp. Med.201(5), 769–777 (2005).
   PubMed Web of Science ®Google Scholar
• Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med.188(2), 287–296 (1998).
   PubMed Web of Science ®Google Scholar
• Ghiringhelli F, Puig PE, Roux S et al. Tumor cells convert immature myeloid dendritic cells into TGF-β-secreting cells inducing CD4+CD25+ regulatory T cell proliferation. J. Exp. Med.202(7), 919–929 (2005).
   PubMed Web of Science ®Google Scholar
• Peng Y, Laouar Y, Li MO, Green EA, Flavell RA. TGF-β regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. Proc. Natl Acad. Sci.101(13), 4572–4577 (2004).
   PubMed Web of Science ®Google Scholar
• Piccirillo CA, Shevach EM. Control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J. Immunol.167(3), 1137–1140 (2001).
   PubMed Web of Science ®Google Scholar
• Smyth MJ, Teng MW, Swann J, Kyparissoudis K, Godfrey DI, Hayakawa Y. CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer. J. Immunol.176(3), 1582–1587 (2006).
   PubMed Web of Science ®Google Scholar
• Ghiringhelli F, Menard C, Terme M et al. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-β-dependent manner. J. Exp. Med.202(8), 1075–1085 (2005).
   PubMed Web of Science ®Google Scholar
• Zhao DM, Thornton AM, Dipaolo RJ, Shevach EM. Activated CD4+CD25+ T cells selectively kill B lymphocytes. Blood, (2006) (Epub ahead of print).
   Google Scholar
• Thornton AM, Shevach EM. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J. Immunol.164(1), 183–189 (2000).
   PubMed Web of Science ®Google Scholar
• Nakamura K, Kitani A, Strober W. Cell contact-dependent immunosuppression by CD4+CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med.194(5), 629–644 (2001).
   PubMed Web of Science ®Google Scholar
• Piccirillo CA, Letterio JJ, Thornton AM et al. CD4+CD25+ regulatory T cells can mediate suppressor function in the absence of transforming growth factor β1 production and responsiveness. J. Exp. Med.196(2), 237–246 (2002).
   PubMed Web of Science ®Google Scholar
• Huang CT, Workman CJ, Flies D et al. Role of LAG-3 in regulatory T cells. Immunity21(4), 503–513 (2004).
   PubMed Web of Science ®Google Scholar
• McHugh RS, Whitters MJ, Piccirillo CA et al. CD4+CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity16(2), 311–323 (2002)
   PubMed Web of Science ®Google Scholar
• Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S. Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol.3(2), 135–142 (2002).
   PubMed Web of Science ®Google Scholar
• Mellor AL, Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol.4(10), 762–774 (2004).
   PubMed Web of Science ®Google Scholar
• Brusko TM, Wasserfall CH, Agarwal A, Kapturczak MH, Atkinson MA. An integral role for heme oxygenase-1 and carbon monoxide in maintaining peripheral tolerance by CD4+CD25+ regulatory T cells. J. Immunol.174(9), 5181–5186 (2005).
   PubMed Web of Science ®Google Scholar
• Gondek DC, Lu LF, Quezada SA, Sakaguchi S, Noelle RJ. Contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol.174(4), 1783–1786 (2005).
   PubMed Web of Science ®Google Scholar
• Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity21(4), 589–601 (2004).
   PubMed Web of Science ®Google Scholar
• Kohm AP, Carpentier PA, Anger HA, Miller SD. CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol.169(9), 4712–4716 (2002).
   PubMed Web of Science ®Google Scholar
• Mottet C, Uhlig HH, Powrie F. Cure of colitis by CD4+CD25+ regulatory T cells. J. Immunol.170(8), 3939–3943 (2003).
   PubMed Web of Science ®Google Scholar
• Morgan ME, Flierman R, van Duivenvoorde LM et al. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum.52(7), 2212–2221 (2005).
   PubMed Web of Science ®Google Scholar
• Mqadmi A, Zheng X, Yazdanbakhsh K. CD4+CD25+ regulatory T cells control induction of autoimmune hemolytic anemia. Blood.105(9), 3746–3748 (2005).
   PubMed Web of Science ®Google Scholar
• Wolf D, Hochegger K, Wolf AM et al. CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice. J. Am. Soc. Nephrol.16(5), 1360–1370 (2005).
   PubMed Web of Science ®Google Scholar
• Masteller EL, Warner MR, Tang Q, Tarbell KV, McDevitt H, Bluestone JA. Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice. J. Immunol.175(5), 3053–3059 (2005).
   PubMed Web of Science ®Google Scholar
• Tang Q, Henriksen KJ, Bi M et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med.199(11), 1455–1465 (2004).
   PubMed Web of Science ®Google Scholar
• Tarbell KV, Yamazaki S, Olson K, Toy P, Steinman RM. CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med.199(11), 1467–1477 (2004).
   PubMed Web of Science ®Google Scholar
• Gangi E, Vasu C, Cheatem D, Prabhakar BS. IL-10-producing CD4+CD25+ regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis. J. Immunol.174(11), 7006–7013 (2005).
   PubMed Web of Science ®Google Scholar
• Kang HK, Michaels MA, Berner BR, Datta SK. Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets. J. Immunol.174(6), 3247–3255 (2005).
   PubMed Web of Science ®Google Scholar
• Trenado A, Sudres M, Tang Q et al. Ex Vivo-expanded CD4+CD25+ immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/differentiation of pathogenic T cells. J. Immunol.176(2), 1266–1273 (2006).
   PubMed Web of Science ®Google Scholar
• Taylor PA, Panoskaltsis-Mortari A, Swedin JM et al. L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood104(12), 3804–3812 (2004).
   PubMed Web of Science ®Google Scholar
• Edinger M, Hoffmann P, Ermann J et al. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat. Med.9(9), 1144–1150 (2003).
   PubMed Web of Science ®Google Scholar
• Jiang S, Herrera O, Lechler RI. New spectrum of allorecognition pathways: implications for graft rejection and transplantation tolerance. Curr. Opin. Immunol.16(5), 550–557 (2004).
   PubMed Web of Science ®Google Scholar
• Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol.3(3), 199–210 (2003).
   PubMed Web of Science ®Google Scholar
• Waldmann H, Cobbold S. Exploiting tolerance processes in transplantation. Science305(5681), 209–212 (2004).
   PubMed Web of Science ®Google Scholar
• Lewkowich IP, Herman NS, Schleifer KW et al. CD4+CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function. J. Exp. Med.202(11), 1549–1561 (2005).
   PubMed Web of Science ®Google Scholar
• Kearley J, Barker JE, Robinson DS, Lloyd CM. Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J. Exp. Med.202(11), 1539–1547 (2005).
   PubMed Web of Science ®Google Scholar
• Heuer JG, Zhang T, Zhao J et al. Adoptive transfer of in vitro-stimulated CD4+CD25+ regulatory T cells increases bacterial clearance and improves survival in polymicrobial sepsis.J. Immunol.174(11), 7141–7146 (2005).
   PubMed Web of Science ®Google Scholar
• Godfrey WR, Ge YG, Spoden DJ et al. In vitro-expanded human CD4+CD25+ T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood104(2), 453–461 (2004).
   PubMed Web of Science ®Google Scholar
• Hoffmann P, Eder R, Kunz-Schughart LA, Andreesen R, Edinger M. Large-scale in vitro expansion of polyclonal human CD4+CD25 high regulatory T cells. Blood104(3), 895–903 (2004).
   PubMed Web of Science ®Google Scholar
• Bluestone JA. Regulatory T-cell therapy: is it ready for the clinic? Nat. Rev. Immunol.5(4), 343–349 (2005).
   PubMed Web of Science ®Google Scholar
• Jiang S, Camara N, Lombardi G, Lechler RI. Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo. Blood102(6), 2180–2186 (2003).
   PubMed Web of Science ®Google Scholar
• Mekala DJ, Geiger TL. Immunotherapy of autoimmune encephalomyelitis with redirected CD4+CD25+ T lymphocytes. Blood.105(5), 2090–2092 (2005).
   PubMed Web of Science ®Google Scholar
• Mekala DJ, Alli RS, Geiger TL. IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4+CD25+ T lymphocytes. Proc. Natl Acad. Sci. USA102(33), 11817–11822 (2005).
   PubMed Web of Science ®Google Scholar